News
News
- CORRECTION: BridgeBio and Eidos Present Data from Phase 2 Open Label Extension Suggesting Long-term Tolerability of AG10 and Stabilization of Transthyretin Amyloid Cardiomyopathy Disease Measures
00:58 - GlobeNewswire - BridgeBio and Eidos Present Data from Phase 2 Open Label Extension Suggesting Long-term Tolerability of AG10 and Stabilization of Transthyretin Amyloid Cardiomyopathy Disease Measures
11/16/2019 / 23:30 - GlobeNewswire - Caladrius Biosciences Reports Positive Results for CLBS16 from the ESCaPE-CMD Trial at American Heart Association Scientific Sessions 2019
11/16/2019 / 21:59 - GlobeNewswire - Kiniksa Presents Rilonacept Final Phase 2 Clinical Data at the American Heart Association Scientific Sessions 2019
11/16/2019 / 18:00 - GlobeNewswire - Amarin Announced FDA Advisory Committee Voted Unanimously (16-0) to Recommend Approval of Vascepa® (icosapent ethyl) Capsules Label Expansion to Reduce Cardiovascular Risk Based on Landmark REDUCE-IT® Outcomes Trial
11/14/2019 / 23:34 - GlobeNewswire - Ascendis Pharma Expands TransCon™ PTH Phase 2 PaTH Forward Clinical Trial to Expedite Enrollment of Subjects Previously Treated with NATPARA® in the United States
11/14/2019 / 22:01 - GlobeNewswire - Zealand Pharma completes Phase 3 clinical program for HypoPal® rescue pen, initiates a new Phase 2 clinical proof of concept trial with dasiglucagon, and secures DKK 560 million in additional investment
11/14/2019 / 15:00 - GlobeNewswire - Icahn owns 4.24% stake in HP, pushes Xerox merger
11/14/2019 / 05:23 - TeleTrader - HP Inc. Board Declares Dividend
11/14/2019 / 01:43 - GlobeNewswire - HP Introduces New 3D Printing Subscriptions, Services, and Partnerships to Accelerate Customers’ Digital Manufacturing Journey
11/13/2019 / 15:00 - GlobeNewswire
Real-time